Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Feb;59(2):179–183. doi: 10.1038/bjc.1989.37

Warfarin inhibits metastasis of Mtln3 rat mammary carcinoma without affecting primary tumour growth.

P McCulloch 1, W D George 1
PMCID: PMC2247008  PMID: 2930682

Abstract

Coumarin anticoagulants inhibit metastasis in several animal models, but the mechanism of this effect is uncertain. In order to determine the role of cytotoxic and/or cytostatic actions of coumarins on the tumour cells, we have studied the effects of warfarin on tumour cell growth in a model in which tumour metastasis is inhibited by this drug. Clonogenic assay, growth curve analysis and thymidine labelling index revealed that warfarin had no effects on Mtln3 mammary carcinoma cell growth in vitro at concentrations below 1 mM. The growth rate of subcutaneously implanted Mtln3 tumour deposits in female F344 rats, assessed by weight and by stathmokinetic analysis of the tumour tissue, was identical in warfarin-treated and control animals. Spontaneous metastasis from such tumours to the lungs was, however, significantly reduced in warfarin-treated animals (median 0 pulmonary tumours per animal in warfarin treated, eight tumours per animal in control animals; P less than 0.05, Mann-Whitney). The mean plasma warfarin concentration in warfarin treated rats was 1.63 microM. These results suggest that warfarin treatment of the host animal can inhibit tumour metastasis without having any direct or indirect effect on the growth rate of the tumour cells.

Full text

PDF
179

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown J. M. A study of the mechanism by which anticoagulation with warfarin inhibits blood-borne metastases. Cancer Res. 1973 Jun;33(6):1217–1224. [PubMed] [Google Scholar]
  2. Chang J. C., Hall T. C. In vitro effect of sodium warfarin on DNA and RNA synthesis of mouse L1210 leukemic cells and Walker tumor cells. Oncology. 1973;28(3):232–237. doi: 10.1159/000224819. [DOI] [PubMed] [Google Scholar]
  3. Colucci M., Delaini F., de Bellis Vitti G., Locati D., Poggi A., Semeraro N., Donati M. B. Warfarin inhibits both procoagulant activity and metastatic capacity of Lewis lung carcinoma cells. Role of vitamin K deficiency. Biochem Pharmacol. 1983 Jun 1;32(11):1689–1691. doi: 10.1016/0006-2952(83)90110-7. [DOI] [PubMed] [Google Scholar]
  4. Davis R. B., Theologides A., Kennedy B. J. Comparative studies of blood coagulation and platelet aggregation in patients with cancer and nonmalignant diseases. Ann Intern Med. 1969 Jul;71(1):67–80. doi: 10.7326/0003-4819-71-1-67. [DOI] [PubMed] [Google Scholar]
  5. Dvorak H. F., Dvorak A. M., Manseau E. J., Wiberg L., Churchill W. H. Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression. J Natl Cancer Inst. 1979 Jun;62(6):1459–1472. [PubMed] [Google Scholar]
  6. Goeting N., Trotter G. A., Cooke T., Kirkham N., Taylor I. Effect of warfarin on cell kinetics, epithelial morphology and tumour incidence in induced colorectal cancer in the rat. Gut. 1985 Aug;26(8):807–815. doi: 10.1136/gut.26.8.807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hart I. R., Fidler I. J. Cancer invasion and metastasis. Q Rev Biol. 1980 Jun;55(2):121–142. doi: 10.1086/411730. [DOI] [PubMed] [Google Scholar]
  8. Higashi H., Heidelberger C. Lack of effect of warfarin (NSC-59813) alone or in combination with 5-fluorouracil (NSC-19893) on primary and metastatic L1210 leukemia and adenocarcinoma 755. Cancer Chemother Rep. 1971 Feb;55(1):29–33. [PubMed] [Google Scholar]
  9. Hilgard P., Maat B. Mechanism of lung tumour colony reduction caused by coumarin anticoagulation. Eur J Cancer. 1979 Feb;15(2):183–187. doi: 10.1016/0014-2964(79)90058-6. [DOI] [PubMed] [Google Scholar]
  10. Hilgard P., Schulte H., Wetzig G., Schmitt G., Schmidt C. G. Oral anticoagulation in the treatment of a spontaneously metastasising murine tumour (3LL). Br J Cancer. 1977 Jan;35(1):78–86. doi: 10.1038/bjc.1977.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mannucci P. M., Vaglini M., Maniezzo M., Magni E., Mari D., Cascinelli N. Hemostatic alterations are unrelated to the stage of tumor in untreated malignant melanoma and breast carcinoma. Eur J Cancer Clin Oncol. 1985 Jun;21(6):681–685. doi: 10.1016/0277-5379(85)90265-2. [DOI] [PubMed] [Google Scholar]
  12. McCulloch P., George W. D. Warfarin inhibition of metastasis: the role of anticoagulation. Br J Surg. 1987 Oct;74(10):879–883. doi: 10.1002/bjs.1800741005. [DOI] [PubMed] [Google Scholar]
  13. McNiel N. O., Morgan L. R., Jr Effects of sodium warfarin and sodium heparin plus anticancer agents on growth of rat C6 glioma cells. J Natl Cancer Inst. 1984 Jul;73(1):169–176. [PubMed] [Google Scholar]
  14. Neri A., Nicolson G. L. Phenotypic drift of metastatic and cell-surface properties of mammary adenocarcinoma cell clones during growth in vitro. Int J Cancer. 1981 Dec;28(6):731–738. doi: 10.1002/ijc.2910280612. [DOI] [PubMed] [Google Scholar]
  15. Neri A., Welch D., Kawaguchi T., Nicolson G. L. Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma. J Natl Cancer Inst. 1982 Mar;68(3):507–517. [PubMed] [Google Scholar]
  16. PUCK T. T., STEFFEN J. LIFE CYCLE ANALYSIS OF MAMMALIAN CELLS. I. A METHOD FOR LOCALIZING METABOLIC EVENTS WITHIN THE LIFE CYCLE, AND ITS APPLICATION TO THE ACTION OF COLCEMIDE AND SUBLETHAL DOSES OF X-IRRADIATION. Biophys J. 1963 Sep;3:379–397. doi: 10.1016/s0006-3495(63)86828-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Poste G., Fidler I. J. The pathogenesis of cancer metastasis. Nature. 1980 Jan 10;283(5743):139–146. doi: 10.1038/283139a0. [DOI] [PubMed] [Google Scholar]
  18. Rickles F. R., Edwards R. L. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood. 1983 Jul;62(1):14–31. [PubMed] [Google Scholar]
  19. Ryan J. J., Ketcham A. S., Wexler H. Warfarin therapy as an adjunct to the surgical treatment of malignant tumors in mice. Cancer Res. 1969 Dec;29(12):2191–2194. [PubMed] [Google Scholar]
  20. Ryan J. J., Ketcham A. S., Wexler H. Warfarin treatment of mice bearing autochthonous tumors: effect on spontaneous metastases. Science. 1968 Dec 27;162(3861):1493–1494. doi: 10.1126/science.162.3861.1493. [DOI] [PubMed] [Google Scholar]
  21. Segaloff A. Hormones and breast cancer. Recent Prog Horm Res. 1966;22:351–379. doi: 10.1016/b978-1-4831-9825-5.50012-9. [DOI] [PubMed] [Google Scholar]
  22. Stenflo J., Suttie J. W. Vitamin K-dependent formation of gamma-carboxyglutamic acid. Annu Rev Biochem. 1977;46:157–172. doi: 10.1146/annurev.bi.46.070177.001105. [DOI] [PubMed] [Google Scholar]
  23. Sun N. C., McAfee W. M., Hum G. J., Weiner J. M. Hemostatic abnormalities in malignancy, a prospective study of one hundred eight patients. Part I. Coagulation studies. Am J Clin Pathol. 1979 Jan;71(1):10–16. doi: 10.1093/ajcp/71.1.10. [DOI] [PubMed] [Google Scholar]
  24. Suttie J. W. Mechanism of action of vitamin K: synthesis of gamma-carboxyglutamic acid. CRC Crit Rev Biochem. 1980;8(2):191–223. doi: 10.3109/10409238009105469. [DOI] [PubMed] [Google Scholar]
  25. Wexler H. Accurate identification of experimental pulmonary metastases. J Natl Cancer Inst. 1966 Apr;36(4):641–645. doi: 10.1093/jnci/36.4.641. [DOI] [PubMed] [Google Scholar]
  26. Williamson R. C., Lyndon P. J., Tudway A. J. Effects of anticoagulation and ileal resection on the development and spread of experimental intestinal carcinomas. Br J Cancer. 1980 Jul;42(1):85–94. doi: 10.1038/bjc.1980.206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Zacharski L. R., Henderson W. G., Rickles F. R., Forman W. B., Cornell C. J., Jr, Forcier R. J., Edwards R. L., Headley E., Kim S. H., O'Donnell J. F. Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate. Final report of VA Cooperative Study #75. Cancer. 1984 May 15;53(10):2046–2052. doi: 10.1002/1097-0142(19840515)53:10<2046::aid-cncr2820531007>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES